Table 2. Concomitant medication by medical specialty.
| Safety population (N=637) | |
|---|---|
| Concomitant medication usage | |
| Yes | 420 (65.9) |
| No | 217 (34.1) |
| Classifications of concomitant medicationa | |
| Genitourinary system | 311 (74.1) |
| Cardiovascular and hematopoietic systems | 129 (30.7) |
| Central nervous system | 70 (16.7) |
| Gastrointestinal and hepatobiliary systems | 66 (15.7) |
| Endocrine and metabolic systems | 55 (13.1) |
| Hormones | 19 (4.5) |
| Musculoskeletal system | 20 (4.8) |
| Vitamins and minerals | 16 (3.8) |
| Systemic anti-infectives | 17 (4.1) |
| Dermatologicals | 10 (2.4) |
| Respiratory system | 6 (1.4) |
| Allergy and immune systems | 4 (1.0) |
| Oncology | 2 (0.5) |
| Eye | 2 (0.5) |
| Ear and mouth/throat | 1 (0.2) |
| Nutrition | 1 (0.2) |
| Miscellaneous | 1 (0.2) |
Values are presented as number (%). aCoding dictionary: Korean Index of Medical Specialties. Patients may appear in >1 category.